Abstract:Titanium and its alloys have been widely used as bone implants, but for reduced treatment span, improvements are urgently needed to achieve faster and better osteointegration. In this study, we found that miR-132-3p inhibited bone-marrow-derived stem cell (BMSC) osteogenic differentiation via targeting BMP2, and that inhibiting miR-132-3p could significantly improve the osteogenic capability of BMSCs. Moreover, we fabricated a biocompatible selenomethionine (SEMET)-modified polyethylene glycol (PEG)/polyethylenimine (PEI) nanoparticle (SeNP) cross-linked with 0.2% gelatin solutions and delivered miR-132-3p inhibitor to biofunctionalize alkali heat-treated titanium implants, resulting in the development of a novel coating for reverse transfection. The biological performances of PEG/PEI/miR-132-3p inhibitor and SeNP/miR-132-3p inhibitor-biofunctionalized titanium were compared. The biological effects, including cell viability, cytotoxicity, adhesion, cellular uptake, and osteogenic capacity of SeNP/miR-132-3p inhibitor-biofunctionalized titanium implants, were then assessed. Results showed that SeNPs presented appropriate morphology, diameter, and positive zeta potential for efficient gene delivery. The transfection efficiency of the SeNP/miR-132-3p inhibitor was comparable to that of the PEG/PEI/miR-132-3p inhibitor, but the former induced less reactive oxygen species (ROS) production and lower apoptosis rates. Confocal laser scanning microscopy (CLSM) demonstrated that SeNP/miR-132-3p inhibitor nanoparticles released from the titanium surfaces and were taken up by adherent BMSCs. In addition, the release profile showed that transfection could obtain a long-lasting silencing effect for more than 2 weeks. The cell viability, cytotoxicity, and cell spreading of SeNP/miRNA-132-3p inhibitor-biofunctionalized titanium were comparable with those of untreated titanium and the SeNP/miRNA-132-3p inhibitor negative control (NC)-biofunctionalized titanium but resulted in higher ALP activity and osteogenic gene expression levels. In vivo animal studies further certified that SeNP/miRNA-132-3p inhibitor nanoparticles from titanium surfaces promoted osteointegration, which was revealed by microcomputed tomography (micro-CT) and histological observations. Taken together, these findings suggested that selenomethionine-modified PEI-based nanoparticles could achieve better biocompatibility. Moreover, titanium implants biofunctionalized by SeNP/miRNA-132-3p inhibitor nanoparticles might have significant clinical potential for more effective osteointegration.

Multilayer modification on titanium surface for in situ delivery of MicroRNAs

Influence of Multilayer Rhbmp-2 DNA Coating on the Proliferation and Differentiation of MC3T3-E1 Cells Seeded on Roughed Titanium Surface.

Fabrication, Characterization, and Biological Assessment of Multilayer DNA Coatings on Sandblasted-Dual Acid Etched Titanium Surface.

Polyelectrolyte Multilayer Coating with Two Regulatory Molecules on Titanium: Construction and Its Biological Effects

Minocycline-incorporated Multilayers on Titanium Substrates for Simultaneous Regulation of MSCs and Macrophages

Multilayered Coating of Titanium Implants Promotes Coupled Osteogenesis and Angiogenesis in Vitro and in Vivo.

Functionalizing Titanium Surface with PAMAM Dendrimer and Human BMP2 Gene Via Layer-by-layer Assembly for Enhanced Osteogenesis.

Regulation of the Differentiation of Mesenchymal Stem Cells in Vitro and Osteogenesis in Vivo by Microenvironmental Modification of Titanium Alloy Surfaces

Fabrication of Dopamine-Modified Hyaluronic Acid/Chitosan Multilayers on Titanium Alloy by Layer-By-Layer Self-Assembly for Promoting Osteoblast Growth

Surface Mediated in Situ Differentiation of Mesenchymal Stem Cells on Gene-Functionalized Titanium Films Fabricated by Layer-By-Layer Technique

Multilayered Coating on Titanium for Controlled Release of Antimicrobial Peptides for the Prevention of Implant-Associated Infections

Establishing Antibacterial Multilayer Films on the Surface of Direct Metal Laser Sintered Titanium Primed with Phase-Transited Lysozyme

Surface modification of titanium with Heparin-Chitosan multilayers via layer-by-layer self-assembly technique

Construction of multilayered molecular reservoirs on a titanium alloy implant for combinational drug delivery to promote osseointegration in osteoporotic conditions.

Surface Functionalization of Titanium Implants with Chitosan-Catechol Conjugate for Suppression of ROS-induced Cells Damage and Improvement of Osteogenesis

Peptide LL-37 coating on micro-structured titanium implants to facilitate bone formation in vivo via mesenchymal stem cell recruitment

Titanium Surfaces Functionalized with Simir31hg Promote Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.

Multifunctional Prosthesis Surface: Modification of Titanium with Cinnamaldehyde-Loaded Hierarchical Titanium Dioxide Nanotubes

Selenomethionine-Modified Polyethylenimine-Based Nanoparticles Loaded with Mir-132-3p Inhibitor-Biofunctionalized Titanium Implants for Improved Osteointegration.

A micro/nano-biomimetic coating on titanium orchestrates osteo/angio-genesis and osteoimmunomodulation for advanced osseointegration

Coating Polyelectrolyte Multilayers Loaded with Quercetin on Titanium Surfaces by Layer-By-Layer Assembly Technique to Improve Surface Osteogenesis under Osteoporotic Condition.